Cognitive
Pinealon
Ala-Glu-Asp-Arg tripeptide bioregulator studied for cognitive protection.
- Route
- Intranasal, subcutaneous
Overview
Pinealon is another Khavinson short peptide, hypothesised to modulate gene expression in neuronal and pineal tissue.
Mechanism of action
Proposed to interact directly with DNA regulatory sequences, altering transcription of neuroprotective and antioxidant genes.
Evidence base
Russian studies suggest cognitive and mood benefits in aged cohorts; independent Western replication is lacking.
Typical dosing
Common protocol: 5–10 mg intranasal or subcutaneous, in 10-day cycles. Open the dose calculator →
Safety & contraindications
Reported well tolerated; long-term independent safety data are sparse.
Featured in protocols
Related peptides
Educational reference only. Nothing on this page is medical advice, a prescription, or an offer to sell. Discuss any peptide therapy with a qualified clinician who can evaluate your history and monitoring needs.